immun
factor
implic
normal
brain
develop
brain
disord
pathogenesi
pathogen
infect
food
antigen
penetr
across
gastrointestin
barrier
mean
environment
factor
might
affect
immunerel
neurodevelop
test
gastrointestin
inflamm
associ
schizophrenia
therefor
might
contribut
bloodstream
entri
potenti
neurotrop
milk
gluten
exorphin
andor
immun
activ
food
antigen
igg
antibodi
saccharomyc
cerevisia
asca
marker
intestin
inflamm
bovin
milk
casein
wheatderiv
gluten
infecti
agent
assay
cohort
includ
nonrec
onset
schizophrenia
recent
onset
schizophrenia
nonpsychiatr
control
cohort
includ
first
episod
schizophrenia
asca
marker
significantli
elev
correl
food
antigen
antibodi
recent
onset
nonrec
onset
schizophrenia
compar
control
p
unmed
individu
first
episod
schizophrenia
compar
receiv
antipsychot
p
elev
asca
level
especi
evid
nonrec
onset
femal
p
recent
onset
male
p
male
p
antifood
antigen
antibodi
correl
antibodi
toxoplasma
gondii
intestinallyinfecti
pathogen
particularli
male
recent
onset
schizophrenia
p
conclus
gastrointestin
inflamm
relev
patholog
schizophrenia
appear
occur
absenc
may
modifi
antipsychot
may
link
food
antigen
sensit
microbi
infect
sourc
immun
activ
mental
ill
immun
factor
increasingli
focu
research
explor
geneenvironment
interact
underli
pathophysiolog
schizophrenia
abazyan
et
al
brown
shi
et
al
stefansson
et
al
yolken
torrey
prenat
exposur
microbi
pathogen
trigger
inflammatori
process
may
affect
fetal
neurodevelop
brown
yolken
torrey
food
antigen
also
activ
immun
respons
provid
anoth
mean
environment
factor
might
impact
immunerel
neurodevelop
adult
individu
psychiatr
disord
schizophrenia
bipolar
disord
exhibit
increas
humor
immun
respons
food
microbi
antigen
cascella
et
al
dickerson
et
al
dickerson
et
al
dohan
et
al
reichelt
landmark
sever
et
al
sever
et
al
yolken
torrey
foodspecif
antibodi
respons
result
entri
food
antigen
gener
circul
presum
gastrointestin
gi
inflamm
otherwis
compromis
gi
epitheli
andor
endotheli
barrier
bovin
milk
casein
wheat
gluten
particular
interest
neuropsychiatr
disord
peptid
deriv
act
ligand
opioid
receptor
peripher
central
nervou
system
cade
et
al
dohan
drysdal
et
al
reichelt
et
al
reichelt
stensrud
gi
epitheli
barrier
also
penetr
infect
gut
enter
virus
microorgan
acquir
oral
ingest
determin
individu
schizophrenia
might
possess
gi
barrier
defect
enabl
passag
potenti
detriment
antigen
system
circul
measur
antibodi
antisaccharomyc
cerevisia
marker
intestin
inflamm
use
diagnost
aid
crohn
diseas
ashorn
et
al
desplatjego
et
al
kotz
et
al
mallanth
et
al
oshitani
et
al
compar
measur
marker
exposur
food
antigen
infecti
agent
serum
plasma
individu
nonrec
onset
recent
onset
schizophrenia
medic
unmed
first
episod
schizophrenia
control
histori
psychiatr
ill
experi
found
gi
inflamm
may
provid
common
mechan
multipl
sourc
immun
activ
schizophrenia
might
link
cohort
sheppard
pratt
health
system
baltimor
md
usaon
hundr
ninetythre
individu
nonrec
onset
schizophrenia
individu
recent
onset
schizophrenia
individu
histori
psychiatr
disord
recruit
studi
method
identifi
character
individu
diagnost
group
accord
criteria
defin
dsmiv
previous
describ
sever
et
al
sever
et
al
individu
nonrec
onset
schizophrenia
inclus
criteria
dsmiv
diagnosi
schizophrenia
schizophreniform
disord
schizoaffect
disord
age
inclus
current
receiv
antipsychot
medic
individu
recent
onset
schizophrenia
inclus
criteria
dsmiv
diagnosi
schizophrenia
schizophreniform
disord
schizoaffect
disord
onset
psychot
symptom
first
time
within
past
month
defin
presenc
posit
psychot
symptom
least
moder
sever
last
day
sever
day
occur
sever
time
week
age
inclus
voluntari
admiss
either
inpati
day
hospit
program
individu
without
histori
psychiatr
disord
recruit
post
announc
screen
rule
current
past
psychiatr
disord
structur
clinic
interview
dsmiv
axi
disord
first
control
particip
age
inclus
individu
diagnosi
recent
onset
schizophrenia
averag
durat
ill
year
nonrec
onset
schizophrenia
averag
durat
ill
year
exclus
criteria
three
group
includ
follow
histori
intraven
substanc
abus
mental
retard
clinic
signific
medic
disord
would
affect
cognit
perform
respect
substanc
abus
recent
onset
group
psychosi
occur
context
substanc
abus
intox
withdraw
exclus
criterion
nonrec
onset
schizophrenia
control
group
current
substanc
abus
occur
past
one
month
exclus
criterion
basic
demograph
data
three
cohort
popul
shown
tabl
diagnost
group
differ
significantli
age
sex
ttest
chisquar
test
variabl
includ
multivari
analys
describ
blood
sampl
obtain
venipunctur
plasma
serum
separ
assess
antibodi
assay
describ
studi
approv
institut
review
board
irb
sheppard
pratt
health
system
john
hopkin
medic
institut
follow
establish
guidelin
particip
provid
written
inform
consent
studi
procedur
explain
work
describ
carri
accord
code
ethic
world
medic
associ
declar
helsinki
experi
involv
human
method
identifi
character
individu
first
episod
schizophrenia
accord
criteria
defin
dsmiv
also
previous
describ
lewek
et
al
forti
patient
patient
current
receiv
antipsychot
medic
demograph
data
regard
age
sex
also
list
tabl
region
patient
recruit
gener
homogen
regard
socioeconom
characterist
inform
consent
obtain
studi
particip
procedur
sampl
collect
analysi
approv
ethic
committe
univers
cologn
accord
declar
helsinki
antisaccharomyc
cerevisia
igg
antibodi
asca
measur
accord
manufactur
protocol
use
commerci
avail
kit
orgentec
mainz
germani
igg
antibodi
bovin
milk
casein
wheat
gluten
measur
elisa
use
previous
describ
method
sever
et
al
whole
casein
purchas
sigmaaldrich
st
loui
mo
usa
whole
gluten
extract
wheat
cultivar
cheyenn
previous
describ
samaroo
et
al
brief
casein
gluten
immunoassay
plate
well
incub
protein
carbon
buffer
carbonatebicarbon
ph
sigmaaldrich
st
loui
mo
usa
overnight
plate
block
h
wtvol
human
serum
albumin
sigmaaldrich
st
loui
mo
usa
pb
plate
incub
sampl
dilut
pbst
plate
wash
incub
peroxidaseconjug
goatantihuman
igg
secondari
antibodi
southern
biotech
birmingham
al
usa
hydrogen
peroxid
solut
kpl
protein
research
product
gaithersburg
md
usa
ad
color
develop
absorb
measur
nm
refer
wavelength
nm
autom
microtit
plate
reader
molecular
devic
menlo
park
ca
usa
casein
antibodi
measur
portion
individu
test
studi
previous
report
sever
et
al
commerci
avail
elisa
kit
measur
ebv
igg
influenza
igg
influenza
b
igg
measl
igg
rubella
igg
gondii
igg
purchas
ibl
america
minneapoli
mn
usa
andor
ibl
intern
gmbh
hamburg
germani
kit
purchas
focu
diagnost
cypress
ca
usa
igg
level
infecti
diseas
agent
previous
measur
seri
studi
stanley
divis
john
hopkin
cohort
platetopl
variat
correct
control
meannorm
plate
control
individu
particular
plate
equal
valu
previous
describ
sever
et
al
cohort
control
individu
plate
meannorm
valu
medic
individu
equal
cohort
quantit
antibodi
level
asca
compar
use
ttest
twotail
pvalu
cohort
multipl
linear
regress
correct
age
sex
race
implement
test
intercorrel
asca
food
antigen
infecti
diseas
antigen
igg
antibodi
level
cohort
multipl
linear
regress
correct
age
sex
use
test
correl
among
asca
casein
gluten
antipsychoticposit
versu
antipsychoticna
individu
regress
valu
equal
exceed
p
valu
less
consid
signific
cohort
broke
diagnost
group
accord
sex
race
appli
analys
also
examin
correl
asca
age
statist
analys
perform
stata
version
stata
corp
lp
colleg
station
texa
usa
blood
sampl
obtain
sheppard
pratt
health
system
baltimor
md
usa
level
asca
antibodi
significantli
elev
nonrec
onset
p
recent
onset
schizophrenia
p
compar
control
figur
panel
diagnost
group
broken
accord
sex
femal
nonrec
onset
group
significantli
elev
antibodi
level
compar
control
femal
level
male
two
group
significantli
differ
figur
panel
b
convers
recent
onset
group
male
statist
signific
elev
antibodi
level
compar
control
male
wherea
differ
detect
femal
two
group
figur
panel
b
sheppard
pratt
cohort
level
asca
antibodi
significantli
correl
anticasein
antigluten
igg
nonrec
onset
group
antigluten
igg
recent
onset
group
tabl
follow
sex
stratif
correl
signific
nonrec
onset
femal
compar
control
femal
sex
recent
onset
group
compar
respect
control
group
anticasein
antigluten
igg
level
significantli
correl
asca
antibodi
level
nonpsychiatr
control
group
anticasein
antigluten
level
significantli
correl
group
except
femal
recent
onset
schizophrenia
evalu
effect
therapeut
treatment
marker
correl
use
cohort
sampl
cologn
germani
compris
individu
first
episod
schizophrenia
antipsychoticna
group
individu
asca
level
significantli
higher
p
receiv
antipsychot
medic
figur
panel
group
broken
accord
sex
male
antipsychot
show
significantli
elev
asca
level
figur
panel
b
also
untreat
group
anticasein
antigluten
igg
level
significantli
correl
asca
find
appar
women
antipsychot
tabl
asca
antibodi
food
antigen
significantli
correl
receiv
antipsychot
medic
except
modest
correl
asca
anticasein
igg
men
group
tabl
baltimor
cohort
anticasein
antigluten
igg
level
highli
correl
tabl
determin
correl
reflect
greater
gener
immun
activ
review
previous
collect
cohort
data
antibodi
direct
varieti
pathogen
microorgan
one
except
asca
anticasein
igg
antigluten
igg
level
strongli
correl
infecti
diseas
agent
antibodi
level
diagnost
group
figur
recent
onset
group
observ
signific
correl
casein
igg
gondii
igg
r
p
find
specif
men
group
r
p
men
recent
onset
schizophrenia
also
show
signific
correl
gluten
igg
gondii
igg
r
p
neither
cohort
find
signific
effect
race
age
asca
antibodi
level
asca
correl
antigen
goal
investig
evalu
intestin
inflamm
might
connect
food
antigenassoci
immun
activ
individu
schizophrenia
secondarili
determin
link
affect
antipsychot
medic
gi
inflamm
elev
correl
food
antigen
antibodi
schizophrenia
group
suggest
diseaseassoci
inflamm
one
mean
casein
gluten
may
gain
entri
system
circul
andor
gener
humor
immun
respons
asca
marker
elev
individu
suggest
preval
type
inflamm
earli
cours
diseas
even
treatment
implement
also
found
possibl
associ
gondiigener
intestin
inflamm
antifood
antigen
antibodi
recent
onset
patient
group
infect
gi
tract
therefor
may
one
factor
modul
develop
antibodi
milk
casein
wheat
gluten
year
strong
associ
gi
patholog
psychiatr
disord
report
yet
difficult
distinguish
caus
effect
character
antipsychot
impact
gi
symptom
aland
et
al
buscaino
cascella
et
al
eaton
et
al
haug
et
al
hem
kalaydjian
et
al
pynnonen
et
al
reiter
particularli
pertin
find
autopsi
examin
report
extens
inflammatori
chang
throughout
gi
tract
patient
psychiatr
disord
studi
examin
associ
celiac
diseas
schizophrenia
buscaino
cascella
et
al
dohan
eaton
et
al
hem
kalaydjian
et
al
pynnonen
et
al
reiter
autopsi
result
one
studi
patient
schizophrenia
indic
gastriti
enter
coliti
buscaino
hem
celiac
diseas
establish
risk
factor
develop
schizophrenia
character
inflammatori
damag
intestin
villi
follow
immun
reaction
ingest
wheat
gluten
cascella
et
al
eaton
et
al
kalaydjian
et
al
pynnonen
et
al
studi
collect
support
structur
damag
gi
tract
present
schizophrenia
result
document
via
new
measur
inflamm
gi
patholog
evid
may
occur
independ
antipsychot
medic
first
second
gener
antipsychot
typic
associ
gi
motil
issu
constip
bowel
obstruct
also
like
affect
cytokin
balanc
aspect
immun
function
dean
dome
et
al
mcnamara
et
al
watanab
et
al
baltimor
psychiatr
group
individu
receiv
antipsychot
medic
point
diseas
histori
also
time
assess
possibl
evalu
whether
medic
statu
contribut
girel
correl
therefor
includ
studi
arm
specif
address
medic
issu
comparison
individu
receiv
antipsychot
found
signific
differ
anticasein
antigluten
igg
interassoci
medic
medicationfre
howev
asca
inflamm
marker
predomin
untreat
group
retain
significantli
elev
level
marker
well
correl
antifood
antigen
igg
find
suggest
antipsychot
agent
may
affect
type
degre
gi
inflamm
identifi
asca
diseaseassoci
inflamm
present
start
pharmacolog
treatment
also
evalu
antibodi
level
correl
food
antigen
infecti
diseas
antigen
determin
document
immun
activ
could
result
multipl
type
antigen
creat
nonspecif
activ
immun
state
found
foodbas
antigen
significantli
expectedli
intercorrel
gener
significantli
correl
antibodi
infecti
agent
one
import
except
antibodi
gondii
significantli
associ
anticasein
antibodi
recent
onset
group
baltimor
cohort
protozoan
gondii
neurotrop
parasit
particular
interest
light
associ
develop
schizophrenia
use
model
inflammatori
bowel
diseas
experiment
anim
bereswil
et
al
liesenfeld
mortensen
et
al
schreiner
liesenfeld
torrey
et
al
xiao
et
al
yolken
et
al
find
studi
suggest
infect
protozoan
may
creat
alter
gi
permeabl
turn
may
result
increas
absorpt
partial
digest
casein
gluten
peptid
gondii
relev
schizophrenia
may
therefor
includ
role
agent
intestin
inflamm
addit
role
neurotrop
pathogen
mani
pattern
uncov
studi
sexspecif
howev
full
interpret
associ
limit
low
number
women
recent
onset
schizophrenia
group
group
cohort
medic
antipsychot
nevertheless
elev
asca
antibodi
level
correl
gi
inflamm
casein
gluten
antibodi
found
specif
women
nonrec
onset
schizophrenia
group
suffici
number
sex
male
femal
find
reinforc
pathophysiolog
diseas
treatment
like
impact
men
women
differ
exampl
one
interpret
data
gi
inflamm
men
particularli
preval
earli
resolv
time
wherea
women
may
inflamm
persist
throughout
cours
diseas
overal
result
indic
alter
gi
inflamm
permeabl
may
contribut
etiopathogenesi
andor
symptomatolog
schizophrenia
gene
may
dictat
individu
especi
suscept
environmentallyinduc
barrier
permeabl
issu
recent
identifi
candid
gene
particular
relev
mechan
involv
gi
permeabl
immun
activ
includ
vasoact
intestin
peptid
receptor
major
histocompat
complex
complement
controlrel
gene
havik
et
al
shi
et
al
stefansson
et
al
vacic
et
al
ultim
understand
interact
intestin
inflamm
predispos
genet
factor
may
lead
new
method
identifi
treat
prevent
psychot
disord
quantit
asca
igg
level
individu
schizophrenia
compar
control
co
refer
control
nonro
nonrec
onset
ro
recent
onset
sz
schizophrenia
pvalu
refer
level
statist
signific
follow
twotail
ttest
panel
elev
asca
igg
level
found
individu
nonro
sz
ro
sz
compar
control
panel
b
asca
igg
level
significantli
elev
femal
nonro
sz
compar
femal
control
male
ro
sz
compar
male
control
asca
igg
level
individu
schizophrenia
accord
medic
statu
szunm
refer
antipsychot
schizophrenia
szmed
refer
antipsychoticposit
schizophrenia
pvalu
refer
level
statist
signific
follow
twotail
ttest
panel
asca
igg
level
elev
individu
antipsychot
compar
receiv
medic
panel
b
asca
igg
level
significantli
elev
male
antipsychot
compar
male
antipsychoticposit
correl
gi
inflamm
food
antigen
igg
igg
infecti
diseas
agent
diagnost
group
anticasein
igg
antigluten
igg
asca
antibodi
level
compar
well
igg
infecti
diseas
antigen
anticasein
igg
use
yaxi
compon
shown
repres
chart
refer
antibodi
level
follow
meannorm
absorb
pvalu
refer
level
statist
signific
follow
multipl
linear
regress
correct
age
sex
race
